Stability of mixed micellar systems made by solubilizing phosphatidylcholine-cholesterol vesicles by bile salts. 1990

D Lichtenberg, and S Ragimova, and A Bor, and S Almog, and C Vinkler, and Y Peled, and Z Halpern
Department of Physiology and Pharmacology, Icholov Hospital, Tel-Aviv Medical Center, Israel.

Complete solubilization of phosphatidylcholine and cholesterol by bile salts in the form of stable mixed micelles requires that the effective ratio of bile salt/lipids in the mixed micelles (Re = ([bile salt] - critical micellar concentration)/([phosphatidylcholine] + [cholesterol]) will exceed a critical value. This equilibrium solubilizing ratio is an increasing function of the cholesterol/phosphatidylcholine ratio. In contrast, the concentration of sodium cholate required for solubilization of vesicles made of phosphatidylcholine and cholesterol does not increase by increasing the cholesterol/phosphatidylcholine ratio. Consequently, the latter solubilization procedure yields metastable mixed micelles whenever the cholate concentration is higher than that required for vesicle solubilization but lower than that needed for establishing a micellar equilibrium. These metastable mixed micelles undergo partial revesiculation to form cholesterol-rich vesicles that subsequently aggregate. Cholesterol crystallization appears to occur through its reorganization within these aggregated vesicles. The overall rate of the above series of processes increases sharply with the total lipid concentration and with the cholesterol/phosphatidylcholine ratio. The dependence of the rate on the effective ratio of bile salts/lipids is very complex: at any given ratio of cholesterol/phosphatidylcholine within the range of 0.3 to 0.5, increasing the cholesterol/phosphatidylcholine ratio requires higher cholate concentrations for the formation of stable mixed micelles (higher equilibrium solubilizing ratio). On the other hand, the metastable mixed micellar larsystems are long-lived whenever the effective ratio of cholate/lipids is lower than a critical value.(ABSTRACT TRUNCATED AT 250 WORDS)

UI MeSH Term Description Entries
D008823 Micelles Particles consisting of aggregates of molecules held loosely together by secondary bonds. The surface of micelles are usually comprised of amphiphatic compounds that are oriented in a way that minimizes the energy of interaction between the micelle and its environment. Liquids that contain large numbers of suspended micelles are referred to as EMULSIONS. Micelle
D008954 Models, Biological Theoretical representations that simulate the behavior or activity of biological processes or diseases. For disease models in living animals, DISEASE MODELS, ANIMAL is available. Biological models include the use of mathematical equations, computers, and other electronic equipment. Biological Model,Biological Models,Model, Biological,Models, Biologic,Biologic Model,Biologic Models,Model, Biologic
D010713 Phosphatidylcholines Derivatives of PHOSPHATIDIC ACIDS in which the phosphoric acid is bound in ester linkage to a CHOLINE moiety. Choline Phosphoglycerides,Choline Glycerophospholipids,Phosphatidyl Choline,Phosphatidyl Cholines,Phosphatidylcholine,Choline, Phosphatidyl,Cholines, Phosphatidyl,Glycerophospholipids, Choline,Phosphoglycerides, Choline
D002784 Cholesterol The principal sterol of all higher animals, distributed in body tissues, especially the brain and spinal cord, and in animal fats and oils. Epicholesterol
D001647 Bile Acids and Salts Steroid acids and salts. The primary bile acids are derived from cholesterol in the liver and usually conjugated with glycine or taurine. The secondary bile acids are further modified by bacteria in the intestine. They play an important role in the digestion and absorption of fat. They have also been used pharmacologically, especially in the treatment of gallstones. Bile Acid,Bile Salt,Bile Salts,Bile Acids,Acid, Bile,Acids, Bile,Salt, Bile,Salts, Bile
D012995 Solubility The ability of a substance to be dissolved, i.e. to form a solution with another substance. (From McGraw-Hill Dictionary of Scientific and Technical Terms, 6th ed) Solubilities

Related Publications

D Lichtenberg, and S Ragimova, and A Bor, and S Almog, and C Vinkler, and Y Peled, and Z Halpern
February 1988, The Journal of pharmacy and pharmacology,
D Lichtenberg, and S Ragimova, and A Bor, and S Almog, and C Vinkler, and Y Peled, and Z Halpern
August 1984, Biochimica et biophysica acta,
D Lichtenberg, and S Ragimova, and A Bor, and S Almog, and C Vinkler, and Y Peled, and Z Halpern
March 2017, Scientific reports,
D Lichtenberg, and S Ragimova, and A Bor, and S Almog, and C Vinkler, and Y Peled, and Z Halpern
January 1971, Biochimie,
D Lichtenberg, and S Ragimova, and A Bor, and S Almog, and C Vinkler, and Y Peled, and Z Halpern
July 1976, Biochimica et biophysica acta,
D Lichtenberg, and S Ragimova, and A Bor, and S Almog, and C Vinkler, and Y Peled, and Z Halpern
January 1982, Journal of lipid research,
D Lichtenberg, and S Ragimova, and A Bor, and S Almog, and C Vinkler, and Y Peled, and Z Halpern
May 1973, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.),
D Lichtenberg, and S Ragimova, and A Bor, and S Almog, and C Vinkler, and Y Peled, and Z Halpern
November 1975, Biochimica et biophysica acta,
D Lichtenberg, and S Ragimova, and A Bor, and S Almog, and C Vinkler, and Y Peled, and Z Halpern
June 1999, The Journal of surgical research,
D Lichtenberg, and S Ragimova, and A Bor, and S Almog, and C Vinkler, and Y Peled, and Z Halpern
January 1979, Chemistry and physics of lipids,
Copied contents to your clipboard!